ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-01346
製品名称
Psoriasin/S100A7 Protein, Human, Recombinant
タンパク質名
Psoriasin/S100A7
Species
Human
HOST
E. coli
50μg: -
お問い合わせ

Overview

Synonyms S100 calcium binding protein A7, PSOR1, S100A7c
Characteristics Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Endotoxin Level Please contact us for more information.
Purity 98.30%
Description Protein S100-A7, also known as S100 calcium-binding protein A7, Psoriasin, S100A7, and PSOR1, is a secreted protein which belongs to theS-100 family. S100A7 was first isolated from skin involved by psoriasis, which can be induced in cultured squamous epithelial cells. S100A7 is expressed by both normal cultured and malignant keratinocytes and malignant breast epithelial cells within ductal carcinoma in situ, suggesting an association with abnormal pathways of differentiation. S100A7 plays a role in the pathogenesis of inflammatory skin disease, as a chemotactic factor for hematopoietic cells. It also plays a role in early stages of breast tumor progression in association with the development of the invasive phenotype.
Reference Ohuchida, K.?et al., 2006, Clin Cancer Res??12?(18):5417-22.,Kouno, T. et al., 2008, J Pept Sci. 14?(10):1129-38.Le?n, R. et al., 2009, Biochemistry. 48?(44): 10591-600.,Emberley, ED. et al., 2004, Breast Cancer Res??6?(4): 153-9.,Miyasaki, KT. et al., 1993, J. Dent. Res. 72: 517-23.,Watson, PH. et al., 1998, Int J Biochem Cell Biol??30?(5):567-71.
URL https://www.targetmol.com/recombinant-protein/psoriasin_s100a7_protein_human_recombinant

お問い合わせリスト(-)

お問い合わせフォーム